{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T13:18:58Z","timestamp":1778591938791,"version":"3.51.4"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-11937-1","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T13:06:35Z","timestamp":1778591195000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Preclinical evaluation of anti-orbital ionic calcium compounds reveals differential Annexin V\/PI-Defined cell death profiles in MCF-7 breast cancer cells"],"prefix":"10.1007","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8842-5457","authenticated-orcid":false,"given":"Server","family":"Bozdogan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-3003-6317","authenticated-orcid":false,"given":"Paul","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0584-0661","authenticated-orcid":false,"given":"Cagatay Han","family":"Turkseven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1452-5655","authenticated-orcid":false,"given":"Derya","family":"Yetkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,5,12]]},"reference":[{"issue":"3","key":"11937_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74(3):229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834","journal-title":"CA Cancer J Clin"},{"key":"11937_CR2","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-3890579\/v1","author":"V Zangouri","year":"2024","unstructured":"Zangouri V, Soufizadeh Balaneji S, Deylami I, Zeinalpor A, Mousavi SA, Amestejani M (2024) Comparison of clinicopathologic characteristics and survival outcomes of various subtypes of breast cancer. Res Square. https:\/\/doi.org\/10.21203\/rs.3.rs-3890579\/v1","journal-title":"Res Square"},{"issue":"7","key":"11937_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24076834","volume":"24","author":"L Clusan","year":"2023","unstructured":"Clusan L, Ferri\u00e8re F, Flouriot G, Pakdel F (2023) A basic review on estrogen receptor signaling pathways in breast cancer. Int J Mol Sci 24(7):6834. https:\/\/doi.org\/10.3390\/ijms24076834","journal-title":"Int J Mol Sci"},{"issue":"2","key":"11937_CR4","doi-asserted-by":"publisher","first-page":"313","DOI":"10.3892\/IJO_00000153","volume":"34","author":"Y Tabuchi","year":"2009","unstructured":"Tabuchi Y et al (2009) Resistance to paclitaxel therapy is related with Bcl-2 expression through an estrogen receptor-mediated pathway in breast cancer. Int J Oncol 34(2):313\u2013319. https:\/\/doi.org\/10.3892\/IJO_00000153","journal-title":"Int J Oncol"},{"issue":"3","key":"11937_CR5","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.tibs.2015.12.001","volume":"41","author":"MV Liberti","year":"2016","unstructured":"Liberti MV, Locasale JW (2016) The Warburg effect: how does it benefit cancer cells? Trends Biochem Sci 41(3):211\u2013218. https:\/\/doi.org\/10.1016\/j.tibs.2015.12.001","journal-title":"Trends Biochem Sci"},{"key":"11937_CR6","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/nrc.2017.18","volume":"17","author":"GR Monteith","year":"2017","unstructured":"Monteith GR, Prevarskaya N, Roberts-Thomson SJ (2017) The calcium\u2013cancer signalling nexus. Nat Rev Cancer 17:367\u2013380. https:\/\/doi.org\/10.1038\/nrc.2017.18","journal-title":"Nat Rev Cancer"},{"key":"11937_CR7","doi-asserted-by":"publisher","first-page":"5623","DOI":"10.1002\/jcp.26277","volume":"233","author":"A Tajbakhsh","year":"2018","unstructured":"Tajbakhsh A et al (2018) The current status and perspectives regarding the clinical implication of intracellular calcium in breast cancer. J Cell Physiol 233:5623\u20135641. https:\/\/doi.org\/10.1002\/jcp.26277","journal-title":"J Cell Physiol"},{"key":"11937_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2017.00070","volume":"7","author":"H Ivanova","year":"2017","unstructured":"Ivanova H, Kerkhofs M, Rovere RM, Bultynck G (2017) Endoplasmic reticulum\u2013mitochondrial Ca\u00b2\u207a fluxes underlying cancer cell survival. Front Oncol 7:70. https:\/\/doi.org\/10.3389\/fonc.2017.00070","journal-title":"Front Oncol"},{"key":"11937_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0217712","volume":"14","author":"A Glenister","year":"2019","unstructured":"Glenister A, Simone M, Hambley T (2019) A Warburg effect targeting vector designed to increase uptake of compounds by cancer cells. PLoS One 14:e0217712. https:\/\/doi.org\/10.1371\/journal.pone.0217712","journal-title":"PLoS One"},{"key":"11937_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20123017","volume":"20","author":"E Varghese","year":"2019","unstructured":"Varghese E et al (2019) Anti-cancer agents in proliferation and cell death: the calcium connection. Int J Mol Sci 20:3017. https:\/\/doi.org\/10.3390\/ijms20123017","journal-title":"Int J Mol Sci"},{"key":"11937_CR11","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41416-019-0650-z","volume":"122","author":"N Koundouros","year":"2019","unstructured":"Koundouros N, Poulogiannis G (2019) Reprogramming of fatty acid metabolism in cancer. Br J Cancer 122:4\u201322. https:\/\/doi.org\/10.1038\/s41416-019-0650-z","journal-title":"Br J Cancer"},{"issue":"2","key":"11937_CR12","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1042\/BJ1010480","volume":"101","author":"FL Bygrave","year":"1966","unstructured":"Bygrave FL (1966) The effect of calcium ions on the glycolytic activity of Ehrlich ascites-tumour cells. Biochem J 101(2):480\u2013487. https:\/\/doi.org\/10.1042\/BJ1010480","journal-title":"Biochem J"},{"key":"11937_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12906-016-1136-2","volume":"16","author":"V Kuete","year":"2016","unstructured":"Kuete V et al (2016) Cytotoxicity of selected natural compounds against breast cancer cells. BMC Complement Altern Med 16:1\u201312. https:\/\/doi.org\/10.1186\/s12906-016-1136-2","journal-title":"BMC Complement Altern Med"},{"key":"11937_CR14","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1016\/j.biopha.2018.11.078","volume":"109","author":"S Razak","year":"2019","unstructured":"Razak S et al (2019) Anticancer mechanisms of bioactive compounds in MCF-7 cells. Biomed Pharmacother 109:1692\u20131702. https:\/\/doi.org\/10.1016\/j.biopha.2018.11.078","journal-title":"Biomed Pharmacother"},{"key":"11937_CR15","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1002\/jcb.30745","volume":"126","author":"T Limboonreung","year":"2025","unstructured":"Limboonreung T et al (2025) Calcium-mediated cytotoxicity in breast cancer models. J Cell Biochem 126:112\u2013124. https:\/\/doi.org\/10.1002\/jcb.30745","journal-title":"J Cell Biochem"},{"issue":"6","key":"11937_CR16","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1080\/10408440591034502","volume":"35","author":"EJ Calabrese","year":"2005","unstructured":"Calabrese EJ (2005) Cancer biology and hormesis: human tumor cell lines commonly display hormetic (biphasic) dose responses. Crit Rev Toxicol 35(6):463\u2013582. https:\/\/doi.org\/10.1080\/10408440591034502","journal-title":"Crit Rev Toxicol"},{"issue":"2","key":"11937_CR17","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1191\/0960327102ht217oa","volume":"21","author":"EJ Calabrese","year":"2002","unstructured":"Calabrese EJ, Baldwin LA (2002) Defining hormesis. Hum Exp Toxicol 21(2):91\u201397. https:\/\/doi.org\/10.1191\/0960327102ht217oa","journal-title":"Hum Exp Toxicol"},{"issue":"1","key":"11937_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.arr.2007.08.007","volume":"7","author":"MP Mattson","year":"2008","unstructured":"Mattson MP (2008) Hormesis defined. Ageing Res Rev 7(1):1\u20137. https:\/\/doi.org\/10.1016\/j.arr.2007.08.007","journal-title":"Ageing Res Rev"},{"key":"11937_CR19","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ceca.2018.06.003","volume":"74","author":"A Tajbakhsh","year":"2018","unstructured":"Tajbakhsh A et al (2018) Calcium signaling and cancer cell death. Cell Calcium 74:123\u2013134. https:\/\/doi.org\/10.1016\/j.ceca.2018.06.003","journal-title":"Cell Calcium"},{"key":"11937_CR20","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.canlet.2019.01.028","volume":"448","author":"E Varghese","year":"2019","unstructured":"Varghese E et al (2019) Metabolic stress and cancer therapy. Cancer Lett 448:37\u201346. https:\/\/doi.org\/10.1016\/j.canlet.2019.01.028","journal-title":"Cancer Lett"},{"key":"11937_CR21","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/nrc.2017.18","volume":"17","author":"GR Monteith","year":"2017","unstructured":"Monteith GR et al (2017) Calcium signaling and cancer progression. Nat Rev Cancer 17:367\u2013380. https:\/\/doi.org\/10.1038\/nrc.2017.18","journal-title":"Nat Rev Cancer"},{"key":"11937_CR22","doi-asserted-by":"publisher","first-page":"568","DOI":"10.3390\/ijms17040568","volume":"17","author":"C Cui","year":"2016","unstructured":"Cui C et al (2016) Calcium homeostasis in cancer. Int J Mol Sci 17:568. https:\/\/doi.org\/10.3390\/ijms17040568","journal-title":"Int J Mol Sci"},{"key":"11937_CR23","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1016\/j.bbamcr.2017.05.004","volume":"1864","author":"H Ivanova","year":"2017","unstructured":"Ivanova H et al (2017) Endoplasmic reticulum\u2013mitochondrial calcium signaling in apoptosis. Biochim Biophys Acta 1864:1519\u20131529. https:\/\/doi.org\/10.1016\/j.bbamcr.2017.05.004","journal-title":"Biochim Biophys Acta"},{"key":"11937_CR24","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.freeradbiomed.2017.11.009","volume":"115","author":"KS Lee","year":"2018","unstructured":"Lee KS et al (2018) Oxidative stress and calcium-induced apoptosis. Free Radic Biol Med 115:92\u2013102. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2017.11.009","journal-title":"Free Radic Biol Med"},{"key":"11937_CR25","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ceca.2016.02.004","volume":"60","author":"S Marchi","year":"2016","unstructured":"Marchi S, Pinton P (2016) The mitochondrial calcium uniporter complex. Cell Calcium 60:77\u201385. https:\/\/doi.org\/10.1016\/j.ceca.2016.02.004","journal-title":"Cell Calcium"},{"issue":"16","key":"11937_CR26","doi-asserted-by":"publisher","first-page":"9357","DOI":"10.1074\/jbc.273.16.9357","volume":"273","author":"RU J\u00e4nicke","year":"1998","unstructured":"J\u00e4nicke RU, Sprengart ML, Wati MR, Porter AG (1998) Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J Biol Chem 273(16):9357\u20139360. https:\/\/doi.org\/10.1074\/jbc.273.16.9357","journal-title":"J Biol Chem"},{"issue":"3","key":"11937_CR27","doi-asserted-by":"publisher","first-page":"231","DOI":"10.4048\/jbc.2016.19.3.231","volume":"19","author":"S Wang","year":"2016","unstructured":"Wang S, He M, Li L, Liang Z, Zou Z, Tao A (2016) Cell-in-cell death is not restricted by Caspase-3 deficiency in MCF-7 cells. J Breast Cancer 19(3):231\u2013241. https:\/\/doi.org\/10.4048\/jbc.2016.19.3.231","journal-title":"J Breast Cancer"},{"key":"11937_CR28","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/s41419-019-1673-2","volume":"10","author":"Y Gongsheng","year":"2019","unstructured":"Gongsheng Y et al (2019) Necrosis as a therapeutic outcome in cancer. Cell Death Dis 10:453. https:\/\/doi.org\/10.1038\/s41419-019-1673-2","journal-title":"Cell Death Dis"},{"key":"11937_CR29","doi-asserted-by":"publisher","first-page":"102295","DOI":"10.1016\/j.redox.2022.102295","volume":"52","author":"X Liu","year":"2022","unstructured":"Liu X et al (2022) Oxidative stress\u2013induced necrosis in cancer cells. Redox Biol 52:102295. https:\/\/doi.org\/10.1016\/j.redox.2022.102295","journal-title":"Redox Biol"},{"key":"11937_CR30","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.tibs.2015.12.001","volume":"41","author":"MV Liberti","year":"2016","unstructured":"Liberti MV, Locasale JW (2016) The Warburg effect: how does it benefit cancer cells? Trends Biochem Sci 41:211\u2013218. https:\/\/doi.org\/10.1016\/j.tibs.2015.12.001","journal-title":"Trends Biochem Sci"},{"key":"11937_CR31","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.3892\/or.2018.6905","volume":"41","author":"P Khongthong","year":"2019","unstructured":"Khongthong P et al (2019) PI3K\/Akt signaling in ER-positive breast cancer. Oncol Rep 41:1011\u20131020. https:\/\/doi.org\/10.3892\/or.2018.6905","journal-title":"Oncol Rep"},{"key":"11937_CR32","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.3390\/cancers14051134","volume":"14","author":"X Peng","year":"2022","unstructured":"Peng X et al (2022) NF-\u03baB signaling and breast cancer progression. Cancers 14:1134. https:\/\/doi.org\/10.3390\/cancers14051134","journal-title":"Cancers"},{"key":"11937_CR33","doi-asserted-by":"publisher","first-page":"102592","DOI":"10.1016\/j.ctrv.2024.102592","volume":"121","author":"KM de la Harpe","year":"2024","unstructured":"de la Harpe KM et al (2024) Targeting necrosis in apoptosis-resistant cancers. Cancer Treat Rev 121:102592. https:\/\/doi.org\/10.1016\/j.ctrv.2024.102592","journal-title":"Cancer Treat Rev"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11937-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-11937-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11937-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T13:06:36Z","timestamp":1778591196000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-11937-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,12]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["11937"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-11937-1","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,12]]},"assertion":[{"value":"15 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Ethical approval was not required for this study, as it was conducted exclusively using an established human cancer cell line (MCF-7) and did not involve human participants or animal subjects.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"750"}}